S.Amdt. 1546Senate119th Congress (2025-2027)
S.Amdt. 1546
Sponsored by
Sen. Elizabeth Warren (D-MA)
Submitted April 3, 2025
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
April 3, 2025
Text
Submitted
SA 1546. Ms. WARREN (for herself and Mr. Markey) submitted an amendment intended to be proposed by her to the concurrent resolution H. Con. Res. 14, establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; which was ordered to lie on the table; as follows: At the appropriate place, insert the following: SEC. ___. POINT OF ORDER AGAINST CONSIDERATION OF ANY LEGISLATION UNTIL THE CAP ON NIH FUNDING FOR RESEARCH AND CLINICAL TRIALS ON RARE DISEASES, CHRONIC DISEASES, PEDIATRIC DISEASES, CANCER, ALZHEIMER'S DISEASE, DIABETES, AND CYSTIC FIBROSIS IS LIFTED. (a) Point of Order.--It shall not be in order in the Senate to consider any bill, joint resolution, motion, amendment, amendment between the Houses, or conference report until the date on which the 15 percent cap on the use of National Institutes of Health funding for indirect costs is lifted for institutions that conduct research or clinical trials on rare diseases, chronic diseases, pediatric diseases, cancer, Alzheimer's disease, diabetes, or cystic fibrosis. (b) Waiver and Appeal.--Subsection (a) may be waived or suspended in the Senate only by an affirmative vote of three- fifths of the Members, duly chosen and sworn. An affirmative vote of three-fifths of the Members of the Senate, duly chosen and sworn, shall be required to sustain an appeal of the ruling of the Chair on a point of order raised under subsection (a). ______